Glycerin Suppositories for Treatment of Feeding Intolerance in Preterm Infants
NCT02149407 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 230
Last updated 2015-04-03
Summary
Feeding intolerance is a common problem in preterm infants.
Conditions
- Feeding Intolerance
Interventions
- DRUG
-
Glycerin
Glycerin group "GG" will receive the 0.5 suppository (700 mg) twice daily for 48 hours. We will use the rounded part and discard the other part then will hold baby's buttocks for 2 minutes to ensure its delivery.
- PROCEDURE
-
Rectal stimulation
Rectal stimulation "SG" by soft cotton swab inserted to around 3 cm. The stick will press against the rectal wall in all direction for 2 minutes twice daily for 48 hours. Ky gel will be used to lubricate the stick and minimize direct friction to rectal wall.
- OTHER
-
Control
Control group "CG" will receive routine NICU medical care without any specific intervention for the infant. The research nurse will do shame placebo twice daily by opening his diaper to blind the team for 2 minutes.
Sponsors & Collaborators
-
Sulaiman Al Habib Medical Group- Arrayan Hospital
collaborator UNKNOWN -
King Saud Medical City
lead OTHER_GOV
Principal Investigators
-
Latifa Almahmoud, MD · KSMC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2016-05-31
- Completion
- 2016-08-31
Countries
- Saudi Arabia
Study Locations
More Related Trials
-
Feeding Intolerance in Formula-Fed Infants
NCT02028156 ·Status: TERMINATED ·Phase: NA
-
Bifidobacterium Supplementation for Very Low Birth Weight Infants
NCT01375309 ·Status: COMPLETED ·Phase: NA
-
To Assess the Safety and Tolerance of Infant Formula With Locust Bean Gum in Infants With Regurgitation
NCT04042454 ·Status: COMPLETED ·Phase: NA
-
Lactose Intolerance in Infants With Gastrointestinal Disturbances
NCT06789068 ·Status: COMPLETED ·Phase: NA
-
Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial
NCT01441427 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Oropharyngeal Administration of Mother's Milk in Preterm Infants and Gastrointestinal Motility
NCT03552510 ·Status: COMPLETED ·Phase: NA
-
Tolerance of Healthy Term Infants Fed Infant Formulas #4
NCT01155414 ·Status: COMPLETED ·Phase: PHASE3
-
Management of Infant Digestive Disorders and Quality of Life
NCT04462640 ·Status: COMPLETED
-
Effect of Formula on Infant Behavior
NCT02746016 ·Status: COMPLETED ·Phase: NA
-
HMF Preterm Case Studies
NCT05057390 ·Status: COMPLETED ·Phase: NA
-
Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates
NCT07088302 ·Status: RECRUITING ·Phase: NA
-
Tolerance of Healthy Infants Fed Infant Formulas
NCT02401217 ·Status: COMPLETED ·Phase: NA
-
Re-feeding Gastric Residuals in Preterm Infants
NCT01420263 ·Status: COMPLETED ·Phase: NA
-
Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Term Infants
NCT00798382 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Novel PIONEER© Protocol: RCT
NCT07035912 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Feeding Tolerance in Preterm Infants
NCT00450697 ·Status: UNKNOWN
-
Behavior of Infants Fed Formula Supplemented With Prebiotics
NCT02757924 ·Status: COMPLETED ·Phase: NA
-
Gastrointestinal Symptoms and Tolerance in Infants Fed Goat or Cow's Milk-based Infant Formula
NCT07342972 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Feeding Intolerance in Preterm Infant
NCT06693557 ·Status: NOT_YET_RECRUITING
-
Effects of Parenteral Nutrition With Different Lipid Emulsions in Preterm Infants
NCT01683162 ·Status: UNKNOWN ·Phase: PHASE4
-
Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs)
NCT06212427 ·Status: RECRUITING ·Phase: NA
-
Acceptability and Gastrointestinal Tolerance of a High-Sn-2 Infant Formula
NCT02598817 ·Status: COMPLETED
-
Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula
NCT01573871 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
NCT02510560 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Cisapride in Premature Infants With Feeding Problems
NCT01281566 ·Status: TERMINATED ·Phase: PHASE4